One of the first studies to imply that the CB2 receptor may be implicated in depression was that of Onaivi et al., where they demonstrated that CB2 protein levels measured by western immunoblotting in whole brain extract were enhanced in mice subjected to CMS for a period of 4 weeks [61,69]. Here, CNR2 is linked to depressive symptom measurement.